Juan-Jose Ventura
Overview
Explore the profile of Juan-Jose Ventura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Janssens R, Barbier L, Muller M, Cleemput I, Stoeckert I, Whichello C, et al.
Front Pharmacol
. 2023 Sep;
14:1192770.
PMID: 37663265
Patients have unique insights and are (in-)directly affected by each decision taken throughout the life cycle of medicinal products. Patient preference studies (PPS) assess what matters most to patients, how...
2.
Cortesi E, Meeusen B, Vanstapel A, Verleden S, Vanaudenaerde B, Wuyts W, et al.
Cells
. 2021 Dec;
10(12).
PMID: 34943945
Chronic lung diseases (CLDs) represent a set of disorders characterized by the progressive loss of proper lung function. Among severe CLDs, the incidence of chronic obstructive pulmonary disease (COPD) and...
3.
Abreu de Oliveira W, Moens S, El Laithy Y, van der Veer B, Athanasouli P, Cortesi E, et al.
Front Oncol
. 2021 Aug;
11:705384.
PMID: 34367990
Triple-Negative Breast Cancer (TNBC) is the most aggressive breast cancer subtype, characterized by limited treatment options and higher relapse rates than hormone-receptor-positive breast cancers. Chemotherapy remains the mainstay treatment for...
4.
Meeusen B, Cortesi E, Omella J, Sablina A, Ventura J, Janssens V
Cancer Lett
. 2021 Jul;
520:57-67.
PMID: 34216687
KRAS-mutant lung adenocarcinomas represent the largest molecular subgroup of non-small cell lung cancers (NSCLC) and are notorious for their dismal survival perspectives. To gain more insights in etiology and therapeutic...
5.
Cortesi E, Ventura J
J Lung Health Dis
. 2019 Jun;
3(1):12-15.
PMID: 31236545
Lung cancer is the leading cause of cancer-related deaths worldwide with poor prognosis, mainly due to the delay in the diagnosis. Adenocarcinoma, a subtype of non-small cell lung cancer, has...
6.
Ceulemans A, Verhulst S, Van Haele M, Govaere O, Ventura J, van Grunsven L, et al.
Cell Death Dis
. 2017 Nov;
8(11):e3164.
PMID: 29095436
Hepatic progenitor cells (HPCs) are small cells with a relative large oval nucleus and a scanty cytoplasm situated in the canals of Hering that express markers of (immature) hepatocytes and...
7.
8.
Guinot A, Oeztuerk-Winder F, Ventura J
Cancer Res
. 2016 May;
76(13):4012-22.
PMID: 27197183
Defining the molecular and cellular roots of lung cancer relapse after initial treatment remains an imperative to improve survival. Here we report that the lung stem cell marker Lgr6 becomes...
9.
Josue Ruiz E, Oeztuerk-Winder F, Ventura J
Nat Commun
. 2014 Jan;
5:3175.
PMID: 24430801
The signals that regulate stem cell self-renewal and differentiation in the lung remain elusive. Lung stem cells undergo self-renewal or lineage commitment to replenish tissue, depending on cross-talk with their...
10.
Voisset E, Oeztuerk-Winder F, Ruiz E, Ventura J
PLoS One
. 2013 Nov;
8(11):e78911.
PMID: 24265727
Lung cancer is the cause of most cancer-related deaths in the Western world. Non-small cell lung cancer accounts for almost 80% of all lung cancers, and 50% of this type...